209 related articles for article (PubMed ID: 18812968)
1. CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities.
Stevenson CB; Ehtesham M; McMillan KM; Valadez JG; Edgeworth ML; Price RR; Abel TW; Mapara KY; Thompson RC
Neurosurgery; 2008 Sep; 63(3):560-9; discussion 569-70. PubMed ID: 18812968
[TBL] [Abstract][Full Text] [Related]
2. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.
Rempel SA; Dudas S; Ge S; Gutiérrez JA
Clin Cancer Res; 2000 Jan; 6(1):102-11. PubMed ID: 10656438
[TBL] [Abstract][Full Text] [Related]
3. T2 detection of tumor invasion within segmented components of glioblastoma multiforme.
McMillan KM; Ehtesham M; Stevenson CB; Edgeworth ML; Thompson RC; Price RR
J Magn Reson Imaging; 2009 Feb; 29(2):251-7. PubMed ID: 19161171
[TBL] [Abstract][Full Text] [Related]
4. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
Bian XW; Yang SX; Chen JH; Ping YF; Zhou XD; Wang QL; Jiang XF; Gong W; Xiao HL; Du LL; Chen ZQ; Zhao W; Shi JQ; Wang JM
Neurosurgery; 2007 Sep; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
[TBL] [Abstract][Full Text] [Related]
5. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
Hoelzinger DB; Mariani L; Weis J; Woyke T; Berens TJ; McDonough WS; Sloan A; Coons SW; Berens ME
Neoplasia; 2005 Jan; 7(1):7-16. PubMed ID: 15720813
[TBL] [Abstract][Full Text] [Related]
7. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
[TBL] [Abstract][Full Text] [Related]
8. Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I-IV astrocytic brain tumors.
Lange F; Kaemmerer D; Behnke-Mursch J; Brück W; Schulz S; Lupp A
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1227-1237. PubMed ID: 29696364
[TBL] [Abstract][Full Text] [Related]
9. The role of CXCR4 in highly malignant human gliomas biology: current knowledge and future directions.
Gagliardi F; Narayanan A; Reni M; Franzin A; Mazza E; Boari N; Bailo M; Zordan P; Mortini P
Glia; 2014 Jul; 62(7):1015-23. PubMed ID: 24715652
[TBL] [Abstract][Full Text] [Related]
10. Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies.
Jarboe JS; Johnson KR; Choi Y; Lonser RR; Park JK
Cancer Res; 2007 Sep; 67(17):7983-6. PubMed ID: 17804706
[TBL] [Abstract][Full Text] [Related]
11. CXCR4 expression mediates glioma cell invasiveness.
Ehtesham M; Winston JA; Kabos P; Thompson RC
Oncogene; 2006 May; 25(19):2801-6. PubMed ID: 16407848
[TBL] [Abstract][Full Text] [Related]
12. CXCL12 and CXCR4 as predictive biomarkers of glioma recurrence pattern after total resection.
Tang W; Wang X; Chen Y; Zhang J; Chen Y; Lin Z
Pathol Biol (Paris); 2015 Sep; 63(4-5):190-8. PubMed ID: 26277915
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
14. The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour.
Smith SJ; Diksin M; Chhaya S; Sairam S; Estevez-Cebrero MA; Rahman R
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156557
[TBL] [Abstract][Full Text] [Related]
15. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.
Tanwar MK; Gilbert MR; Holland EC
Cancer Res; 2002 Aug; 62(15):4364-8. PubMed ID: 12154041
[TBL] [Abstract][Full Text] [Related]
16. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
17. The regulation of cysteine cathepsins and cystatins in human gliomas.
Gole B; Huszthy PC; Popović M; Jeruc J; Ardebili YS; Bjerkvig R; Lah TT
Int J Cancer; 2012 Oct; 131(8):1779-89. PubMed ID: 22287159
[TBL] [Abstract][Full Text] [Related]
18. ELTD1, a potential new biomarker for gliomas.
Towner RA; Jensen RL; Colman H; Vaillant B; Smith N; Casteel R; Saunders D; Gillespie DL; Silasi-Mansat R; Lupu F; Giles CB; Wren JD
Neurosurgery; 2013 Jan; 72(1):77-90; discussion 91. PubMed ID: 23096411
[TBL] [Abstract][Full Text] [Related]
19. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma multiforme: clinical findings, magnetic resonance imaging, and pathology in five dogs.
Lipsitz D; Higgins RJ; Kortz GD; Dickinson PJ; Bollen AW; Naydan DK; LeCouteur RA
Vet Pathol; 2003 Nov; 40(6):659-69. PubMed ID: 14608019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]